http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200500369-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d15a4a3ede0e6e55194a1679d68c89e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-14
filingDate 2004-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c0016a335c8a19744ee525be3469e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdced0492a696b6126526beac8034aac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9b521a08f0245e12a39d78a06afa9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817edd09cbb63a2c5b07ae25aae6e466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0d17a8547466a95049897af30b1420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eab2f654727da437fdfc290e7b20aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8089c188ab5c897555683129ee4d199d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26805d40e3ff3af19d5c6f4101a55385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff219c87a7d9466311be3fc553ab303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf3b74bea82cb1097a9dae77fb8b0ec
publicationDate 2005-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200500369-A
titleOfInvention Cephem compounds
abstract The present invention relates to a compound of the formula [I]: , wherein R1 is lower alkyl which may have suitable substituent(s), R2 is amino, protected amino or guanidine, R3 is carboxy or protected carboxy, R4 is amino or protected amino, and A is lower alkylene, or pharmaceutically acceptable salt thereof, a process for Preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.
priorityDate 2003-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3520

Total number of triples: 30.